Skip to main content

What the FDA labels say about taking them together

Caspofungin and tacrolimus

Caspofungin's FDA label of October 11, 2024 names tacrolimus in its drug interactions section, and tacrolimus's label names caspofungin too. The tacrolimus label: “Caspofungin May decrease tacrolimus whole blood trough concentrations.”

Check it at the source: the caspofungin FDA label on DailyMed (effective October 11, 2024, Merck Sharp & Dohme LLC); the tacrolimus FDA label on DailyMed (effective July 17, 2026, Stellon Biotech Inc.).

What does the caspofungin label say about tacrolimus?

Caspofungin label, drug interactions

For patients receiving CANCIDAS and tacrolimus, standard monitoring of tacrolimus trough whole blood concentrations and appropriate tacrolimus dosage adjustments are recommended.

Source: FDA drug label (Caspofungin Acetate, NDA206110), Fresenius Kabi USA, LLC, effective January 8, 2026 (SPL set e76d8d83-3691-451c-a32c-d91448c54d16), via openFDA

Source: FDA drug label (CANCIDAS), Merck Sharp & Dohme LLC, effective October 11, 2024 (SPL set 3bad23a6-09a6-4194-9182-093ed61bc71c), via openFDA; the full label on DailyMed

What does the tacrolimus label say about caspofungin?

Tacrolimus label, drug interactions

Caspofungin May decrease tacrolimus whole blood trough concentrations.

Source: FDA drug label (Tacrolimus), Stellon Biotech Inc., effective July 17, 2026 (SPL set 6b89e8a4-9f11-42e3-8e79-fe617e7c461f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Caspofungin generic labelers
33Tacrolimus generic labelers
CaspofunginTacrolimus
Labeled forFungal infectionsOrgan transplant rejection, Eczema (atopic dermatitis)
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.970 per gram 0.1% ointment
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?